The inflammatory MSCs contribute to the pathology of RA by releasing soluble mediators, including cytokines and proteolytic enzymes (including matrix metalloproteases (MMPs), cathepsins, and serine proteases), which directly or indirectly promote cartilage degradation [21,22]. The gene discussed is CTSS; the disease is rheumatoid arthritis.